NIK1 antibodies are immunoglobulin-based reagents designed to bind specifically to the NIK protein. In mammalian systems, NIK (MAP3K14) regulates immune responses and cell survival through NF-κB activation . In plants, NIK1 is a receptor-like kinase involved in antiviral defense mechanisms . This article focuses on the mammalian NIK antibody due to its commercial availability and well-documented applications.
NIK1 antibodies enable the study of NF-κB signaling pathways, which are critical in inflammation, lymphoid organ development, and B-cell maturation . For example:
Detects endogenous NIK expression levels in immune cell lysates .
Facilitates analysis of NIK phosphorylation states under cytokine stimulation .
Although not directly related to the commercial #4994 antibody, plant NIK1 studies reveal its role in antiviral immunity:
Antiviral Action: NIK1 phosphorylates ribosomal protein RPL10, suppressing viral mRNA translation .
Bacterial Immunity Modulation: NIK1 inhibits FLS2/BAK1 complex formation, reducing antibacterial responses .
Genetic Evidence: nik1-1 mutants exhibit enhanced resistance to Pseudomonas syringae but increased susceptibility to RNA/DNA viruses .
Cross-Reactivity: The #4994 antibody does not recognize plant NIK1 homologs .
Validation: Ensure antibody specificity via knockout controls in WB experiments .
Storage: Follow manufacturer guidelines (-20°C in aliquots) to preserve activity .
KEGG: cal:CAALFM_C702800WA